Poly(ADP-ribose) Polymerase-1 (PARP-1) Contributes to the Barrier Function of a Vertebrate Chromatin Insulator

被引:10
|
作者
Aker, Mari [1 ]
Bomsztyk, Karol [2 ]
Emery, David W. [1 ,2 ,3 ]
机构
[1] Univ Washington, Div Med Genet, Seattle, WA 98195 USA
[2] Univ Washington, UW Med Lake Union, Dept Med, Seattle, WA 98195 USA
[3] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
BETA-GLOBIN INSULATOR; ENHANCER BLOCKING; DNA-BINDING; CTCF; TRANSCRIPTION; PROTEINS; VECTORS;
D O I
10.1074/jbc.M110.174532
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The prototypic chromatin insulator cHS4 has proven effective in reducing silencing chromosomal position effects in a variety of settings. Most of this barrier insulator activity has been mapped to a 250-bp core region, as well as to several proteins that bind this region. However, recent studies from our laboratory demonstrated that an extended 400-bp core region of the cHS4 element is necessary to achieve full barrier insulator activity when used as a single copy in the context of recombinant gammaretroviral and lentiviral vectors. In this study, electrophoretic gel mobility shift assays revealed specific DNA-protein binding activities associated with the distal portion of this extended core region. Affinity purification and tandem mass spectrometry studies led to the identification of one of these proteins as poly(ADP-ribose) polymerase-1 (PARP-1). The identity of this binding activity as PARP-1 was subsequently verified by a variety of biochemical studies in vitro and by chromatin immunoprecipitation studies in vivo. Functional studies with gammaretroviral reporter vectors in cell lines and primary mouse bone marrow progenitor cultures showed that cHS4 barrier activity was abrogated upon mutation of the putative PARP1-binding site or upon treatment with a PARP inhibitor, respectively. The barrier activity of the cHS4 element was also found to be abrogated in studies using bone marrow from Parp1-null mice. Taken together, this study demonstrates that binding of PARP-1 plays a key functional role in the barrier activity of the extended cHS4 insulator core element.
引用
收藏
页码:37589 / 37597
页数:9
相关论文
共 50 条
  • [31] Poly(ADP-ribose) polymerase-1 (Parp-1)-deficient mice demonstrate abnormal antibody responses
    Ambrose, Helen E.
    Willimott, Shaun
    Beswick, Richard W.
    Dantzer, Francoise
    de Murcia, Josiane Menissier
    Yelamos, Jose
    Wagner, Simon D.
    IMMUNOLOGY, 2009, 127 (02) : 178 - 186
  • [32] Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage
    Moroni, Flavio
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (01) : 96 - 103
  • [33] Inhibition of poly (ADP-ribose) polymerase-1 (PARP-1) as a strategy for targeted therapy in Ewing's sarcoma
    Brenner, J. Chad
    Feng, Felix Y.
    Han, Sumin
    Bou-Maroun, Laura M.
    Patel, Sonam
    Goyal, Siddharth V.
    Liu, Meilan
    Lonigro, Robert
    Prensner, John R.
    Tomlins, Scott A.
    Chinnaiyan, Arul M.
    CANCER RESEARCH, 2012, 72
  • [34] Poly (ADP-ribose) polymerase-1 (PARP-1) genetic variants are protective against Parkinson's disease
    Infante, Jon
    Sanchez-Juan, Pascual
    Mateo, Ignacio
    Rodriguez-Rodriguez, Eloy
    Sanchez-Quintana, Coro
    Llorca, Javier
    Fontalba, Ana
    Terrazas, Jesus
    Oterino, Agustin
    Berciano, Jose
    Combarros, Onofre
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 256 (1-2) : 68 - 70
  • [35] MEDI 303-Design and synthesis of novel inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1)
    Patel, Maulik R.
    Pino, Maria
    Billack, Blase
    Talele, Tanaji T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [36] Production, extraction, and purification of human poly(ADP-ribose) polymerase-1 (PARP-1) with high specific activity
    Knight, MI
    Chambers, PJ
    PROTEIN EXPRESSION AND PURIFICATION, 2001, 23 (03) : 453 - 458
  • [37] Gemcitabine Induces Poly (ADP-Ribose) Polymerase-1 (PARP-1) Degradation through Autophagy in Pancreatic Cancer
    Wang, Yufeng
    Kuramitsu, Yasuhiro
    Tokuda, Kazuhiro
    Baron, Byron
    Kitagawa, Takao
    Akada, Junko
    Maehara, Shin-ichiro
    Maehara, Yoshihiko
    Nakamura, Kazuyuki
    PLOS ONE, 2014, 9 (10):
  • [38] Discovery of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor clinical candidate CEP-9722
    Hudkins, Robert L.
    Zulli, Allison L.
    Diebold, James L.
    Wells, Greg
    Aimone, Lisa D.
    Husten, Jean
    Miknyoczki, Sheila
    Ruggeri, Bruce A.
    Ator, Mark A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [39] Discovery and SAR of novel, potent and selective hexahydrobenzonaphthyridinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)
    Torrisi, Caterina
    Bisbocci, Monica
    Ingenito, Raffaele
    Ontoria, Jesus M.
    Rowley, Michael
    Schultz-Fademrecht, Carsten
    Toniatti, Carlo
    Jones, Philip
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (02) : 448 - 452
  • [40] The Zn3 Domain of Human Poly(ADP-ribose) Polymerase-1 (PARP-1) Functions in Both DNA-dependent Poly(ADP-ribose) Synthesis Activity and Chromatin Compaction
    Langelier, Marie-France
    Ruhl, Donald D.
    Planck, Jamie L.
    Kraus, W. Lee
    Pascal, John M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (24) : 18877 - 18887